This was a systematic review and meta-analysis looking at the potential benefits of lactoferrin for preventing late-onset sepsis (LOS) and necrotizing enterocolitis (NEC) in preterm infants. Nine RCT’s were included in the analysis which involved a total of 1834 patients. Of the 9 studies NEC was the primary outcome measure of 5 studies. In these 5 studies lactoferrin supplementation showed a significant reduction in the incidence of NEC.
References:
He, Y., Cao, L., & Yu, J. (2018). Prophylactic lactoferrin for preventing late-onset sepsis and necrotizing enterocolitis in preterm infants: A PRISMA-compliant systematic review and meta-analysis. Medicine, 97(35), e11976. https://doi.org/10.1097/MD.0000000000011976